Skip to content

Motor tempo tuning via personalized alpha-burst non-invasive brain stimulation

Motor tempo tuning via personalized alpha-burst non-invasive brain stimulation - Motor tempo tuning via personalized alpha-burst non-invasive brain stimulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000052245
Enrollment
20
Registered
2023-09-19
Start date
2023-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy adult

Interventions

Prior to the examination, structural brain data will be obtained by MRI. The intervention involves four rTMS conditions, including sham stimulation, applied to the dorsolateral prefrontal cortex using

Sponsors

Tohoku University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Healthy adult 2. Right handed

Exclusion criteria

Exclusion criteria: 1) Individuals who have proximity to metallic objects near the stimulation site (such as cochlear implants, magnetic clips, deep brain stimulation or vagus nerve stimulation devices) or are using a cardiac pacemaker. 2) Individuals with implanted medical devices containing metal (such as internally implanted drug pumps, those using metal stents or bone replacement devices made of materials like titanium within the skull, or individuals with metal-containing dentures or implants). 3) Individuals who have a history of epilepsy or seizures. 4) Individuals taking medications that may increase the risk of seizures (such as tricyclic antidepressants, maprotiline, theophylline, methylphenidate, ketamine, clozapine, zotepine, etc.). 5) Individuals with alcohol dependence or caffeine dependence. 6) Pregnant individuals or those with severe underlying medical conditions. 7) Individuals with upper limb (hand or arm) motor impairments. 8) Individuals taking the following medications: (a) Medications to relieve symptoms such as fever, headache, or cough (anti-inflammatory pain relievers, cough suppressants, over-the-counter cold remedies, etc.). (b) Medications to alleviate nasal congestion or allergy symptoms. 9)Individuals with poor health or feeling unwell on the day of the examination

Design outcomes

Primary

MeasureTime frame
Finger tapping speed, tempo and stability.

Secondary

MeasureTime frame
EEG 1) alpha power 2) alpha associated coherence of different cortical regions

Countries

Japan

Contacts

Public ContactRyoichi Nagatomi

Tohoku University Graduate School of Biomedical Engineering

nagatomi@med.tohoku.ac.jp022-717-8586

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026